242 related articles for article (PubMed ID: 11274402)
1. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.
Kaji H; Canaff L; Lebrun JJ; Goltzman D; Hendy GN
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3837-42. PubMed ID: 11274402
[TBL] [Abstract][Full Text] [Related]
2. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
3. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.
Hendy GN; Kaji H; Sowa H; Lebrun JJ; Canaff L
Horm Metab Res; 2005 Jun; 37(6):375-9. PubMed ID: 16001330
[TBL] [Abstract][Full Text] [Related]
4. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
5. Functional studies of the MEN1 gene.
Chandrasekharappa SC; Teh BT
J Intern Med; 2003 Jun; 253(6):606-15. PubMed ID: 12755956
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage.
Sowa H; Kaji H; Canaff L; Hendy GN; Tsukamoto T; Yamaguchi T; Miyazono K; Sugimoto T; Chihara K
J Biol Chem; 2003 Jun; 278(23):21058-69. PubMed ID: 12649288
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.
Shattuck TM; Costa J; Bernstein M; Jensen RT; Chung DC; Arnold A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
9. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells.
Ratineau C; Bernard C; Poncet G; Blanc M; Josso C; Fontanière S; Calender A; Chayvialle JA; Zhang CX; Roche C
J Biol Chem; 2004 Jun; 279(23):24477-84. PubMed ID: 15054094
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
11. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
[TBL] [Abstract][Full Text] [Related]
12. Menin is required for optimal processing of the microRNA let-7a.
Gurung B; Muhammad AB; Hua X
J Biol Chem; 2014 Apr; 289(14):9902-8. PubMed ID: 24563463
[TBL] [Abstract][Full Text] [Related]
13. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene.
Sukhodolets KE; Hickman AB; Agarwal SK; Sukhodolets MV; Obungu VH; Novotny EA; Crabtree JS; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Mol Cell Biol; 2003 Jan; 23(2):493-509. PubMed ID: 12509449
[TBL] [Abstract][Full Text] [Related]
14. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
15. Menin and bone metabolism.
Kaji H
J Bone Miner Metab; 2012 Jul; 30(4):381-7. PubMed ID: 22543820
[TBL] [Abstract][Full Text] [Related]
16. Menin inactivation leads to loss of transforming growth factor beta inhibition of parathyroid cell proliferation and parathyroid hormone secretion.
Sowa H; Kaji H; Kitazawa R; Kitazawa S; Tsukamoto T; Yano S; Tsukada T; Canaff L; Hendy GN; Sugimoto T; Chihara K
Cancer Res; 2004 Mar; 64(6):2222-8. PubMed ID: 15026366
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation.
Verrecchia F; Pessah M; Atfi A; Mauviel A
J Biol Chem; 2000 Sep; 275(39):30226-31. PubMed ID: 10903323
[TBL] [Abstract][Full Text] [Related]
18. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.
Poisson A; Zablewska B; Gaudray P
Cancer Lett; 2003 Jan; 189(1):1-10. PubMed ID: 12445671
[TBL] [Abstract][Full Text] [Related]
19. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
20. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
Selvamurugan N; Kwok S; Partridge NC
J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
